An interventional study of Integration in Arthritis, Asthma and Chronic Obstructive Lung Disease, sponsored by University of Vermont. Status unknown at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-10-05.
Sponsored by University of Vermont · Not applicable, Interventional, and Health services research
Behavioral problems are part of many of the chronic diseases that cause the majority of illness, disability and death. Tobacco, diet, physical inactivity, alcohol, drug abuse, failure to take treatment, sleep problems, anxiety, depression, and stress are major issues, especially when chronic medical problems such as heart disease, lung disease, diabetes, or kidney disease are also present. These behavioral problems can often be helped, but the current health care system doesn't do a good job of getting the right care to these patients.
Behavioral health includes mental health care, substance abuse care, health behavior change, and attention to family and other psychological and social factors. Many people with behavioral health needs present to primary care and may be referred to mental health or substance abuse specialists, but this method is often unacceptable to patients. Two newer ways have been proposed for helping these patients. In co-location, a behavioral health clinician (such as a Psychologist or Social Worker) is located in or near the primary practice to increase the chance that the patient will make it to treatment. In Integrated Behavioral Health (IBH), a Behavioral Health Clinician is specially trained to work closely with the medical provider as a full member of the primary treatment team.
The research question is: Does increased integration of evidence-supported behavioral health and primary care services, compared to simple co-location of providers, improve outcomes? The key decision affected by the research is at the practice level: whether and how to use behavioral health services.
The investigators plan to do a randomized, parallel group clustered study of 3,000 subjects in 40 practices with co-located behavioral health services. Practices randomized to the active intervention will convert to IBH using a practice improvement method that has helped in other settings. The investigators will measure the health status of patients in each practice before and after they start using IBH. The investigators will compare the change in those outcomes to health status changes of patients in practices who have not yet started using IBH.
The investigators plan to study adults who have both medical and behavioral problems, and get their care in Family Medicine clinics, General Internal Medicine practices, and Community Health Centers.
The chronic diseases that drive the majority of mortality, morbidity and cost in America and around the globe are largely behavioral in origin or management. Tobacco, diet, physical inactivity, alcohol, substance abuse, non-adherence to treatment, insomnia, anxiety, depression, and stress are major causes of morbidity, mortality and expense, especially when chronic medical problems such as heart disease, lung disease, diabetes, or arthritis are also present. Behavioral problems can often be effectively managed with improved outcomes for patients, their families and the health care system, but the current health care system is often unable to provide such care.
Behavioral Health includes mental health care, substance abuse care, health behavior change, and attention to family and other psychosocial factors. Many people with behavioral health needs present to primary care and may be referred to mental health or substance abuse specialists, but this method is often unacceptable to patients. Two newer models have been proposed for helping these patients. In co-location, a behavioral health provider is located in or near the primary practice to increase the likelihood of successful referral and treatment initiation. An alternative is Integrated Behavioral Health (IBH) in which a Behavioral Health Clinician is specially trained to work closely with the medical provider as a full member of the primary treatment team. Although it is clear that the status quo of under-diagnosis or inadequate referral and treatment is not acceptable, it is not known which of the alternative models is best.
The research question is: Does increased integration of evidence-supported behavioral health and primary care services, compared to simple co-location of providers, improve patient-centered outcomes in patients with multiple morbidities? The key health decisions affected by the research are those made at the practice level: whether and how best to incorporate behavioral health (BH) services. At the patient level, the decision of whether to seek out or accept offered BH services will be influenced by the manner they are made available.
Aim 1: Determine if increased integration of evidence-supported behavioral health and primary care results in better patient-centered outcomes than simple co-location of behavioral providers without systematic integration.
Aim 2: Determine if structured improvement process techniques are effective in increasing BH integration.
Aim 3: Explore how contextual factors affect the implementation and patient centeredness of integrated BH care.
Aim 4: Assess the costs of implementing integration in this setting.
Aim 5: Covid Enhancement: What is the effect of the pandemic upon the effectiveness of IBH?
This is a prospective, cluster-randomized, mixed methods comparison of co-location of BH services vs. IBH in 3,000 subjects in 40 primary care practices around the US.
Usual care (the control comparator) for practices attempting to deliver BH services is co-location of a BH clinician within or adjacent to the primary care facility, without increased integration. The active comparator (the intervention) is Integrated Behavioral Health to support the delivery of protocol supported, stepped, data-driven, evidence-supported, BH care. In both cases, the expenses (such as salaries for the Behavioral Health Clinicians) will be paid by the practices. The intervention consists of training for practice leaders, Behavioral Health Clinicians, primary care providers, and office staff, a Structured Improvement Process support for practice redesign, and a toolkit of suggested tactics for implementing BH.
The target patient population is adults with multiple comorbid medical and behavioral problems receiving services in the target practice settings: Family Medicine clinics, General Internal Medicine practices, and Community Health Centers. The investigators will enroll 40 practices from around the country to represent a broad spectrum of US primary care sites including those serving racial and ethnic minority groups, low-income groups, women, seniors, residents of rural areas, and patients with special health needs, disabilities, multiple chronic diseases, low health literacy or numeracy and/or limited English proficiency. The intervention will be directed at the practices and its impact measured in a randomly selected sample of 75 patients with behavioral health needs from each practice for a total of 3000 patients followed for 2 years.
The primary outcome is the PROMIS-29, a patient-centered measure of global health and functioning. Secondary analyses will assess other outcomes important to patients as well subgroup analyses to allow exploration of what types of patients and practices benefit most from Integrated Behavioral Health. Aim 2 will study the effect of the intervention on practice structure and processes. Aim 3 will identify barriers and supports for successful integration. Aim 4 will assess costs of implementation.
The analyses for Aims 1 and 2 will use generalized linear mixed models of patient health status to perform intention-to-treat analyses as a function of experimental condition (co-location vs. integration), patient characteristics, and time of measurement, with multiple measures clustered within patients and patients clustered within practices. The parameters of interest are the central tendency (mean), statistical significance (P values) and 95% confidence intervals (CI) of the adjusted change in PROMIS-29 domain score since before the intervention. Each of the 8 outcome domains in the PROMIS-29 will be modeled individually as 8 separate hypotheses with adjustment for multiple comparisons. Secondary outcomes (Communication, Empathy, Adherence, etc.) will use similar models. Aim 3 will use mixed methods analysis of surveys, focus groups, key informant interviews and other data sources to explore the relationship between the context of the intervention and the patient-centeredness of the resultant care. Aim 4 will use a survey of practice managers in a subset of practices to collect information on staffing changes,staff time, supplies and capital expenses incurred as part of implementation.
1,336 studies on the registry are indexed under Fibromyalgia; 266 are open to participants now.
This study's enrollment of 4,025 is above the median of 60 across 1,035 interventional studies indexed under Fibromyalgia.
Browse Fibromyalgia studies →University of Vermont is the lead sponsor of 215 studies on the registry; 28 are open to participants now.
Of its 16 completed or terminated interventional studies of FDA-regulated products, 9 (56%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
The intervention consists of training for practice leaders, BHCs, PCPs, and office staff, a Protocolized Redesign Process support for practice redesign, and a toolkit of suggested tactics for implementing Tasks A through D: A. Identification B. Assessment C. Treatment D. Surveillance
Other: Integration
A Behavioral Health Clinician (BHC) such as a psychologist or counselor is housed in or near the primary care practice.
The intervention consists of training for practice leaders, BHCs, PCPs, and office staff, a Protocolized Redesign Process support for practice redesign, and a toolkit of suggested tactics for implementing Tasks A through D: A. Identification B. Assessment C. Treatment D. Surveillance
PROMIS-29 v2
Change in general health
Time frame: 24 months
CAHPS 12-Month PCMH Adult Questionnaire 2.0
Quality of provider communication
Time frame: 24 months
Consultation and Relational Empathy measure
Quality of provider empathy
Time frame: 24 months
Patient Activation Measure-13
Self-management
Time frame: 24 months
Modified Self-reported Medication-taking Scale
Medication adherence
Time frame: 24 months
Patient Report of Utilization
Health care utilization
Time frame: 24 months
Restricted Activity Days
Time lost due to disability
Time frame: 24 months
Duke Activity Status Index
Physical Function
Time frame: 24 months
Hgb A1C
Glycemic control
Time frame: 24 months
30-day use
Substance Use disorder \& Problem Drinking
Time frame: 24 months
Global Appraisal of Individual Needs - Short Screener
Substance Use disorder \& Problem Drinking
Time frame: 24 months
Systolic blood pressure
Hypertension
Time frame: 24 months
Asthma Symptom Utility Index
Asthma symptoms
Time frame: 24 months
Staff Burnout
Ancillary study: What is the effect of the IBH-PC intervention on staff burnout?
Time frame: 24 months
Practice Integration Profile
Aim 2: Self-report by practice staff on degree of integration of behavioral and medical services
Time frame: 24 months
Costs of Implementation
Aim 4: Staff time, supplies, capital and other expenses
Time frame: 24 months
Patient Centeredness Index
Patient-report of patient-centeredness of their Primary Care practice
Time frame: 24 months
Covid-19 practice measures
Impact of Covid-19 at the practice level
Time frame: 24-32 months
Covid-19 patient measures
Impact of Covid-19 at the patient level
Time frame: 24-32 months
Plan to share: Yes — A complete, cleaned, de-identified copy of the final dataset used in conducting the final analyses will be made available within one year after the completion of the study. It will include a data dictionary with response and missing values defined as well as a complete set of survey instruments (excluding copyright protected material not licensed for transfer). The data will be available as an encrypted Stata data set or comma-separated file. The investigators will not make data from qualitative results available because of the potential for identifying individuals.
Supporting information: Study protocol, Sap, Icf
This study is status unknown, as verified in Sep 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Vermont